Microbubble-Extracellular Vesicle Complex for Ultrasound Drug Delivery
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current theragnostic agents, particularly those using liposomes, face issues with cytotoxicity, immunogenicity, and limited targeting ability, making them unsuitable for effective drug delivery in medical applications.
Innovation Solution
A microbubble-extracellular vesicle complex is developed, where a microbubble is covalently linked with an extracellular vesicle derived from natural killer cells, human glial cells, or mesenchymal stem cells, and a coupling medium, allowing for ultrasound-driven delivery of therapeutic substances to target sites without cytotoxicity or immunogenicity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If liposomes are used as carriers for theragnostic agents, then drug delivery capability is improved, but cytotoxicity and immunogenicity increase
Solution Approach 1:
The invention changes the material parameter of the carrier from liposomes to extracellular vesicles (specifically exosomes). This parameter change fundamentally alters the biological properties, eliminating cytotoxicity and immunogenicity while maintaining drug delivery capability. The exosomes are isolated from platelet-rich plasma, providing a biocompatible alternative to synthetic liposomes.
Solution Approach 2:
The invention creates a composite structure by conjugating exosomes with microbubbles. The exosome provides biocompatibility and drug loading capacity, while the microbubble provides ultrasound responsiveness and targeting capability. This composite material combines the advantages of both components to achieve effective and safe drug delivery.
2Quantity of substance
If liposomes are used as carriers, then drug loading is improved, but targeting ability is limited
Solution Approach 1:
The exosome-microbubble conjugate serves multiple functions simultaneously: the exosome acts as a drug carrier providing loading capacity, the microbubble provides ultrasound-responsive targeting and release, and the conjugate system enables both diagnosis and therapy. This multi-functionality overcomes the limitation of liposomes which primarily offer only drug loading.
3Measurement precision
If conventional theragnostic agents are used, then diagnosis capability is improved, but therapy effectiveness is restricted
Solution Approach 1:
The invention merges diagnostic and therapeutic functions into a single exosome-microbubble conjugate system. The microbubble provides ultrasound contrast for diagnosis, while the exosome carries therapeutic agents for treatment. Ultrasound activation simultaneously triggers drug release and enhances therapeutic effect, achieving true theragnostic capability where diagnosis and therapy work together rather than separately.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The microbubble-extracellular vesicle complex effectively delivers drugs to target sites in a three-dimensional mode, enhancing targeting ability and avoiding cytotoxicity and immunogenicity, thus providing a novel and safe drug delivery system.
Implementation Method 1
ultrasonic application allows clearer images of internal organs as the ultrasonic waves are reflected by the microbubbles within the contrast agent
Implementation Method 2
the complex can be driven in a three-dimensional mode by an ultrasonic driving device
Data Source
AI summary
Disclosed herein are a microbubble-extracellular vesicle complex, a production method therefor, and a system for driving the same. In one aspect, preferred microbubble-extracellular vesicle complexes may comprise an ultrasound contrast agent-based microbubble, an extracellular cell derived from a natural killer cell (NK cell), a human glial cell, or a human mesenchymal stem cell, and a coupling medium and can be derive in a 3D mode using ultrasonic waves and deliver a drug loaded in the extracellular vesicle to a target site.